ROSS PATRICK VIMR

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology CLACKAMAS, OR NPI 1467719641

General Payments — all program years on this page

$12,696.75

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 95
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $486.83 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $486.8317

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Edwards Lifesciences Corporation $382.5313
Abbott Laboratories $80.921
Penumbra, Inc. $23.383

By program year

Program yearAmountRecords
2018 $2,189.6021
2019 $7,104.4621
2020 $2,195.9124
2021 $127.741
2022 $222.854
2023 $369.367
2024 $486.8317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1076213382 Penumbra, Inc. $5.19 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1095783231 Penumbra, Inc. $11.80 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1095783233 Penumbra, Inc. $6.39 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125080925 Abbott Laboratories $80.92 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892765 Edwards Lifesciences Corporation $19.60 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892767 Edwards Lifesciences Corporation $5.79 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892779 Edwards Lifesciences Corporation $60.35 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892793 Edwards Lifesciences Corporation $12.98 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892795 Edwards Lifesciences Corporation $108.90 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892797 Edwards Lifesciences Corporation $5.75 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892835 Edwards Lifesciences Corporation $48.86 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892837 Edwards Lifesciences Corporation $20.78 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892849 Edwards Lifesciences Corporation $36.46 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892855 Edwards Lifesciences Corporation $8.83 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892861 Edwards Lifesciences Corporation $6.71 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892863 Edwards Lifesciences Corporation $42.22 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138892867 Edwards Lifesciences Corporation $5.30 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.